Bharat Rasayan spurted 7.49% to Rs 10,142.05 after the company said that its board will consider share buyback on Tuesday, 12 January 2021.
Bharat Rasayan's consolidated net profit dropped 35.4% to Rs 35.27 crore on a 12.9% decline in net sales to Rs 318.46 crore in Q2 September 2020 over Q2 September 2019.Bharat Rasayan serves a wide range of industries including but not limited to pharmaceuticals, bulk drugs, R&D, petrochemicals, flavors & fragrances and specialty chemicals.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
